These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1688991)

  • 1. Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction.
    Lacković Z; Salković M
    Life Sci; 1990; 46(1):49-54. PubMed ID: 1688991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-lasting diabetes mellitus on rat and human brain monoamines.
    Lacković Z; Salković M; Kuci Z; Relja M
    J Neurochem; 1990 Jan; 54(1):143-7. PubMed ID: 2293606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptozotocin-induced diabetes reduces brain serotonin synthesis in rats.
    Trulson ME; Jacoby JH; MacKenzie RG
    J Neurochem; 1986 Apr; 46(4):1068-72. PubMed ID: 2419504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebroventricular administration of betacytotoxics alters expression of brain monoamine transporter genes.
    Salković-Petrisić M; Lacković Z
    J Neural Transm (Vienna); 2003 Jan; 110(1):15-29. PubMed ID: 12541010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF; Grose M; Videtic GM; Marliss EB
    Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.
    Szkudelski T
    Physiol Res; 2001; 50(6):537-46. PubMed ID: 11829314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in brain serotonin synthesis rate in streptozotocin-diabetic rats.
    Crandall EA; Gillis MA; Fernstrom JD
    Endocrinology; 1981 Jul; 109(1):310-2. PubMed ID: 6165572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on streptozotocin diabetes.
    Ganda OP; Rossini AA; Like AA
    Diabetes; 1976 Jul; 25(7):595-603. PubMed ID: 132382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice.
    Gaulton GN; Schwartz JL; Eardley DD
    Diabetologia; 1985 Oct; 28(10):769-75. PubMed ID: 2933286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal dopaminergic D1 and D2 receptors after intracerebroventricular application of alloxan and streptozocin in rat.
    Salković M; Sabolić I; Lacković Z
    J Neural Transm Gen Sect; 1995; 100(2):137-45. PubMed ID: 8962683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain indoleamines in alloxan- and streptozotocin-induced diabetic rats.
    Mello LE; Bortolotto ZA; Cavalheiro EA
    J Neurochem; 1988 Sep; 51(3):698-703. PubMed ID: 2970524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Type I Diabetes Mellitus in Beagle Dogs Using Alloxan and Streptozotocin.
    Araujo J; Paradis A; Mendes J; Petrik S; de Rivera C
    Curr Protoc; 2022 Nov; 2(11):e580. PubMed ID: 36326552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of alloxan and streptozotocin induced diabetes in rats: differential effects on microsomal drug metabolism.
    Vega P; Gaule C; Mancilla J; Del Villar E
    Gen Pharmacol; 1993 Mar; 24(2):489-95. PubMed ID: 8482528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemiluminescence as an index of drug-induced free radical production in pancreatic islets.
    Asayama K; English D; Slonim AE; Burr IM
    Diabetes; 1984 Feb; 33(2):160-3. PubMed ID: 6229439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Structural and enzymatic changes in the islets of the rat pancreas following alloxan and streptozotocin administration].
    Hettwer H; Dahlmann B; Marjanovic SD
    Cell Mol Biol Incl Cyto Enzymol; 1978; 23(4):355-67. PubMed ID: 162617
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucoprivic feeding is impaired by lateral or fourth ventricular alloxan injection.
    Ritter S; Murnane JM; Ladenheim EE
    Am J Physiol; 1982 Sep; 243(3):R312-7. PubMed ID: 6214195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor binding is increased in diabetic rats.
    Lozovsky D; Saller CF; Kopin IJ
    Science; 1981 Nov; 214(4524):1031-3. PubMed ID: 6458088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA strand breaks in pancreatic islets by in vivo administration of alloxan or streptozotocin.
    Yamamoto H; Uchigata Y; Okamoto H
    Biochem Biophys Res Commun; 1981 Dec; 103(3):1014-20. PubMed ID: 6460502
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental models in research of the pathomechanism of diabetes mellitus].
    Pusztai P; Prechl J; Somogyi A; Szaleczky E; Fehér J
    Orv Hetil; 1996 Aug; 137(34):1865-9. PubMed ID: 8927340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological responses to acute stress in alloxan and streptozotocin diabetic rats.
    Lee JH; Konarska M; McCarty R
    Physiol Behav; 1989 Mar; 45(3):483-9. PubMed ID: 2526954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.